Serum galectin-3 and presepsin levels were significantly higher in FMF patients during remission than in healthy control subjects, indicating the potential of presepsin and galectin-3 as new biomarkers for predicting disease activity in FMF patients. This evidence concerns the gene LGALS3 and familial Mediterranean fever.